Global Genomic Cancer Testing Market Research Report 2025(Status and Outlook)
Genomic cancer testing, also known as molecular profiling or tumor sequencing, refers to the comprehensive analysis of a patient?s tumor DNA, RNA, and/or proteins to identify specific genetic alterations, mutations, biomarkers, or expression patterns that drive cancer growth and progression. These tests can detect somatic (acquired) mutations, germline (inherited) variants, gene fusions, copy number variations, microsatellite instability (MSI), and tumor mutational burden (TMB), providing critical information for diagnosis, prognosis, treatment selection (including targeted therapy and immunotherapy), and monitoring of treatment response or resistance. Offered in various forms?such as multi-gene panels, whole exome sequencing, whole genome sequencing, and RNA sequencing?genomic cancer testing enables a precision medicine approach by tailoring therapeutic strategies to the individual molecular characteristics of a patient?s cancer, thereby improving clinical outcomes and optimizing resource utilization in oncology care.
The global Genomic Cancer Testing market size was estimated at USD 1650.0 million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 12.50% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Genomic Cancer Testing market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Genomic Cancer Testing market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Genomic Cancer Testing market.
Global Genomic Cancer Testing Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Devyser
Agendia
Illumina
Personal Genome Diagnostics
Veracyte
Pacific Biosciences of California
Qiagen
Agilent Technologies
Natera
Bio Rad Laboratories
Myriad Genetics
Market Segmentation (by Type)
Fluorescence In Situ Hybridization
Polymerase Chain Reaction
Microarray Technology
Serum Proteomics
Nucleic Acid Sequencing
Market Segmentation (by Application)
Hospitals
Speciality Clinics
Research Institutes
Diagnostics Laboratories
Biopharmaceutical Companies
Geographic Segmentation
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Genomic Cancer Testing Market
Overview of the regional outlook of the Genomic Cancer Testing Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Genomic Cancer Testing Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Genomic Cancer Testing, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global Genomic Cancer Testing market size was estimated at USD 1650.0 million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 12.50% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Genomic Cancer Testing market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Genomic Cancer Testing market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Genomic Cancer Testing market.
Global Genomic Cancer Testing Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Devyser
Agendia
Illumina
Personal Genome Diagnostics
Veracyte
Pacific Biosciences of California
Qiagen
Agilent Technologies
Natera
Bio Rad Laboratories
Myriad Genetics
Market Segmentation (by Type)
Fluorescence In Situ Hybridization
Polymerase Chain Reaction
Microarray Technology
Serum Proteomics
Nucleic Acid Sequencing
Market Segmentation (by Application)
Hospitals
Speciality Clinics
Research Institutes
Diagnostics Laboratories
Biopharmaceutical Companies
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Genomic Cancer Testing Market
Overview of the regional outlook of the Genomic Cancer Testing Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Genomic Cancer Testing Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Genomic Cancer Testing, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Genomic Cancer Testing
1.2 Key Market Segments
1.2.1 Genomic Cancer Testing Segment by Type
1.2.2 Genomic Cancer Testing Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 GENOMIC CANCER TESTING MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Genomic Cancer Testing Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Genomic Cancer Testing Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 GENOMIC CANCER TESTING MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Genomic Cancer Testing Product Life Cycle
3.3 Global Genomic Cancer Testing Sales by Manufacturers (2020-2025)
3.4 Global Genomic Cancer Testing Revenue Market Share by Manufacturers (2020-2025)
3.5 Genomic Cancer Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Genomic Cancer Testing Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Genomic Cancer Testing Market Competitive Situation and Trends
3.8.1 Genomic Cancer Testing Market Concentration Rate
3.8.2 Global 5 and 10 Largest Genomic Cancer Testing Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 GENOMIC CANCER TESTING INDUSTRY CHAIN ANALYSIS
4.1 Genomic Cancer Testing Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF GENOMIC CANCER TESTING MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Genomic Cancer Testing Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Genomic Cancer Testing Market
5.7 ESG Ratings of Leading Companies
6 GENOMIC CANCER TESTING MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Genomic Cancer Testing Sales Market Share by Type (2020-2025)
6.3 Global Genomic Cancer Testing Market Size Market Share by Type (2020-2025)
6.4 Global Genomic Cancer Testing Price by Type (2020-2025)
7 GENOMIC CANCER TESTING MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Genomic Cancer Testing Market Sales by Application (2020-2025)
7.3 Global Genomic Cancer Testing Market Size (M USD) by Application (2020-2025)
7.4 Global Genomic Cancer Testing Sales Growth Rate by Application (2020-2025)
8 GENOMIC CANCER TESTING MARKET SALES BY REGION
8.1 Global Genomic Cancer Testing Sales by Region
8.1.1 Global Genomic Cancer Testing Sales by Region
8.1.2 Global Genomic Cancer Testing Sales Market Share by Region
8.2 Global Genomic Cancer Testing Market Size by Region
8.2.1 Global Genomic Cancer Testing Market Size by Region
8.2.2 Global Genomic Cancer Testing Market Size Market Share by Region
8.3 North America
8.3.1 North America Genomic Cancer Testing Sales by Country
8.3.2 North America Genomic Cancer Testing Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Genomic Cancer Testing Sales by Country
8.4.2 Europe Genomic Cancer Testing Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Genomic Cancer Testing Sales by Region
8.5.2 Asia Pacific Genomic Cancer Testing Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Genomic Cancer Testing Sales by Country
8.6.2 South America Genomic Cancer Testing Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Genomic Cancer Testing Sales by Region
8.7.2 Middle East and Africa Genomic Cancer Testing Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 GENOMIC CANCER TESTING MARKET PRODUCTION BY REGION
9.1 Global Production of Genomic Cancer Testing by Region(2020-2025)
9.2 Global Genomic Cancer Testing Revenue Market Share by Region (2020-2025)
9.3 Global Genomic Cancer Testing Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Genomic Cancer Testing Production
9.4.1 North America Genomic Cancer Testing Production Growth Rate (2020-2025)
9.4.2 North America Genomic Cancer Testing Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Genomic Cancer Testing Production
9.5.1 Europe Genomic Cancer Testing Production Growth Rate (2020-2025)
9.5.2 Europe Genomic Cancer Testing Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Genomic Cancer Testing Production (2020-2025)
9.6.1 Japan Genomic Cancer Testing Production Growth Rate (2020-2025)
9.6.2 Japan Genomic Cancer Testing Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Genomic Cancer Testing Production (2020-2025)
9.7.1 China Genomic Cancer Testing Production Growth Rate (2020-2025)
9.7.2 China Genomic Cancer Testing Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Devyser
10.1.1 Devyser Basic Information
10.1.2 Devyser Genomic Cancer Testing Product Overview
10.1.3 Devyser Genomic Cancer Testing Product Market Performance
10.1.4 Devyser Business Overview
10.1.5 Devyser SWOT Analysis
10.1.6 Devyser Recent Developments
10.2 Agendia
10.2.1 Agendia Basic Information
10.2.2 Agendia Genomic Cancer Testing Product Overview
10.2.3 Agendia Genomic Cancer Testing Product Market Performance
10.2.4 Agendia Business Overview
10.2.5 Agendia SWOT Analysis
10.2.6 Agendia Recent Developments
10.3 Illumina
10.3.1 Illumina Basic Information
10.3.2 Illumina Genomic Cancer Testing Product Overview
10.3.3 Illumina Genomic Cancer Testing Product Market Performance
10.3.4 Illumina Business Overview
10.3.5 Illumina SWOT Analysis
10.3.6 Illumina Recent Developments
10.4 Personal Genome Diagnostics
10.4.1 Personal Genome Diagnostics Basic Information
10.4.2 Personal Genome Diagnostics Genomic Cancer Testing Product Overview
10.4.3 Personal Genome Diagnostics Genomic Cancer Testing Product Market Performance
10.4.4 Personal Genome Diagnostics Business Overview
10.4.5 Personal Genome Diagnostics Recent Developments
10.5 Veracyte
10.5.1 Veracyte Basic Information
10.5.2 Veracyte Genomic Cancer Testing Product Overview
10.5.3 Veracyte Genomic Cancer Testing Product Market Performance
10.5.4 Veracyte Business Overview
10.5.5 Veracyte Recent Developments
10.6 Pacific Biosciences of California
10.6.1 Pacific Biosciences of California Basic Information
10.6.2 Pacific Biosciences of California Genomic Cancer Testing Product Overview
10.6.3 Pacific Biosciences of California Genomic Cancer Testing Product Market Performance
10.6.4 Pacific Biosciences of California Business Overview
10.6.5 Pacific Biosciences of California Recent Developments
10.7 Qiagen
10.7.1 Qiagen Basic Information
10.7.2 Qiagen Genomic Cancer Testing Product Overview
10.7.3 Qiagen Genomic Cancer Testing Product Market Performance
10.7.4 Qiagen Business Overview
10.7.5 Qiagen Recent Developments
10.8 Agilent Technologies
10.8.1 Agilent Technologies Basic Information
10.8.2 Agilent Technologies Genomic Cancer Testing Product Overview
10.8.3 Agilent Technologies Genomic Cancer Testing Product Market Performance
10.8.4 Agilent Technologies Business Overview
10.8.5 Agilent Technologies Recent Developments
10.9 Natera
10.9.1 Natera Basic Information
10.9.2 Natera Genomic Cancer Testing Product Overview
10.9.3 Natera Genomic Cancer Testing Product Market Performance
10.9.4 Natera Business Overview
10.9.5 Natera Recent Developments
10.10 Bio Rad Laboratories
10.10.1 Bio Rad Laboratories Basic Information
10.10.2 Bio Rad Laboratories Genomic Cancer Testing Product Overview
10.10.3 Bio Rad Laboratories Genomic Cancer Testing Product Market Performance
10.10.4 Bio Rad Laboratories Business Overview
10.10.5 Bio Rad Laboratories Recent Developments
10.11 Myriad Genetics
10.11.1 Myriad Genetics Basic Information
10.11.2 Myriad Genetics Genomic Cancer Testing Product Overview
10.11.3 Myriad Genetics Genomic Cancer Testing Product Market Performance
10.11.4 Myriad Genetics Business Overview
10.11.5 Myriad Genetics Recent Developments
11 GENOMIC CANCER TESTING MARKET FORECAST BY REGION
11.1 Global Genomic Cancer Testing Market Size Forecast
11.2 Global Genomic Cancer Testing Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Genomic Cancer Testing Market Size Forecast by Country
11.2.3 Asia Pacific Genomic Cancer Testing Market Size Forecast by Region
11.2.4 South America Genomic Cancer Testing Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Genomic Cancer Testing by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)
12.1 Global Genomic Cancer Testing Market Forecast by Type (2026-2033)
12.1.1 Global Forecasted Sales of Genomic Cancer Testing by Type (2026-2033)
12.1.2 Global Genomic Cancer Testing Market Size Forecast by Type (2026-2033)
12.1.3 Global Forecasted Price of Genomic Cancer Testing by Type (2026-2033)
12.2 Global Genomic Cancer Testing Market Forecast by Application (2026-2033)
12.2.1 Global Genomic Cancer Testing Sales (K Units) Forecast by Application
12.2.2 Global Genomic Cancer Testing Market Size (M USD) Forecast by Application (2026-2033)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Genomic Cancer Testing
1.2 Key Market Segments
1.2.1 Genomic Cancer Testing Segment by Type
1.2.2 Genomic Cancer Testing Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 GENOMIC CANCER TESTING MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Genomic Cancer Testing Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Genomic Cancer Testing Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 GENOMIC CANCER TESTING MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Genomic Cancer Testing Product Life Cycle
3.3 Global Genomic Cancer Testing Sales by Manufacturers (2020-2025)
3.4 Global Genomic Cancer Testing Revenue Market Share by Manufacturers (2020-2025)
3.5 Genomic Cancer Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Genomic Cancer Testing Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Genomic Cancer Testing Market Competitive Situation and Trends
3.8.1 Genomic Cancer Testing Market Concentration Rate
3.8.2 Global 5 and 10 Largest Genomic Cancer Testing Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 GENOMIC CANCER TESTING INDUSTRY CHAIN ANALYSIS
4.1 Genomic Cancer Testing Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF GENOMIC CANCER TESTING MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Genomic Cancer Testing Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Genomic Cancer Testing Market
5.7 ESG Ratings of Leading Companies
6 GENOMIC CANCER TESTING MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Genomic Cancer Testing Sales Market Share by Type (2020-2025)
6.3 Global Genomic Cancer Testing Market Size Market Share by Type (2020-2025)
6.4 Global Genomic Cancer Testing Price by Type (2020-2025)
7 GENOMIC CANCER TESTING MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Genomic Cancer Testing Market Sales by Application (2020-2025)
7.3 Global Genomic Cancer Testing Market Size (M USD) by Application (2020-2025)
7.4 Global Genomic Cancer Testing Sales Growth Rate by Application (2020-2025)
8 GENOMIC CANCER TESTING MARKET SALES BY REGION
8.1 Global Genomic Cancer Testing Sales by Region
8.1.1 Global Genomic Cancer Testing Sales by Region
8.1.2 Global Genomic Cancer Testing Sales Market Share by Region
8.2 Global Genomic Cancer Testing Market Size by Region
8.2.1 Global Genomic Cancer Testing Market Size by Region
8.2.2 Global Genomic Cancer Testing Market Size Market Share by Region
8.3 North America
8.3.1 North America Genomic Cancer Testing Sales by Country
8.3.2 North America Genomic Cancer Testing Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Genomic Cancer Testing Sales by Country
8.4.2 Europe Genomic Cancer Testing Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Genomic Cancer Testing Sales by Region
8.5.2 Asia Pacific Genomic Cancer Testing Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Genomic Cancer Testing Sales by Country
8.6.2 South America Genomic Cancer Testing Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Genomic Cancer Testing Sales by Region
8.7.2 Middle East and Africa Genomic Cancer Testing Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 GENOMIC CANCER TESTING MARKET PRODUCTION BY REGION
9.1 Global Production of Genomic Cancer Testing by Region(2020-2025)
9.2 Global Genomic Cancer Testing Revenue Market Share by Region (2020-2025)
9.3 Global Genomic Cancer Testing Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Genomic Cancer Testing Production
9.4.1 North America Genomic Cancer Testing Production Growth Rate (2020-2025)
9.4.2 North America Genomic Cancer Testing Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Genomic Cancer Testing Production
9.5.1 Europe Genomic Cancer Testing Production Growth Rate (2020-2025)
9.5.2 Europe Genomic Cancer Testing Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Genomic Cancer Testing Production (2020-2025)
9.6.1 Japan Genomic Cancer Testing Production Growth Rate (2020-2025)
9.6.2 Japan Genomic Cancer Testing Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Genomic Cancer Testing Production (2020-2025)
9.7.1 China Genomic Cancer Testing Production Growth Rate (2020-2025)
9.7.2 China Genomic Cancer Testing Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Devyser
10.1.1 Devyser Basic Information
10.1.2 Devyser Genomic Cancer Testing Product Overview
10.1.3 Devyser Genomic Cancer Testing Product Market Performance
10.1.4 Devyser Business Overview
10.1.5 Devyser SWOT Analysis
10.1.6 Devyser Recent Developments
10.2 Agendia
10.2.1 Agendia Basic Information
10.2.2 Agendia Genomic Cancer Testing Product Overview
10.2.3 Agendia Genomic Cancer Testing Product Market Performance
10.2.4 Agendia Business Overview
10.2.5 Agendia SWOT Analysis
10.2.6 Agendia Recent Developments
10.3 Illumina
10.3.1 Illumina Basic Information
10.3.2 Illumina Genomic Cancer Testing Product Overview
10.3.3 Illumina Genomic Cancer Testing Product Market Performance
10.3.4 Illumina Business Overview
10.3.5 Illumina SWOT Analysis
10.3.6 Illumina Recent Developments
10.4 Personal Genome Diagnostics
10.4.1 Personal Genome Diagnostics Basic Information
10.4.2 Personal Genome Diagnostics Genomic Cancer Testing Product Overview
10.4.3 Personal Genome Diagnostics Genomic Cancer Testing Product Market Performance
10.4.4 Personal Genome Diagnostics Business Overview
10.4.5 Personal Genome Diagnostics Recent Developments
10.5 Veracyte
10.5.1 Veracyte Basic Information
10.5.2 Veracyte Genomic Cancer Testing Product Overview
10.5.3 Veracyte Genomic Cancer Testing Product Market Performance
10.5.4 Veracyte Business Overview
10.5.5 Veracyte Recent Developments
10.6 Pacific Biosciences of California
10.6.1 Pacific Biosciences of California Basic Information
10.6.2 Pacific Biosciences of California Genomic Cancer Testing Product Overview
10.6.3 Pacific Biosciences of California Genomic Cancer Testing Product Market Performance
10.6.4 Pacific Biosciences of California Business Overview
10.6.5 Pacific Biosciences of California Recent Developments
10.7 Qiagen
10.7.1 Qiagen Basic Information
10.7.2 Qiagen Genomic Cancer Testing Product Overview
10.7.3 Qiagen Genomic Cancer Testing Product Market Performance
10.7.4 Qiagen Business Overview
10.7.5 Qiagen Recent Developments
10.8 Agilent Technologies
10.8.1 Agilent Technologies Basic Information
10.8.2 Agilent Technologies Genomic Cancer Testing Product Overview
10.8.3 Agilent Technologies Genomic Cancer Testing Product Market Performance
10.8.4 Agilent Technologies Business Overview
10.8.5 Agilent Technologies Recent Developments
10.9 Natera
10.9.1 Natera Basic Information
10.9.2 Natera Genomic Cancer Testing Product Overview
10.9.3 Natera Genomic Cancer Testing Product Market Performance
10.9.4 Natera Business Overview
10.9.5 Natera Recent Developments
10.10 Bio Rad Laboratories
10.10.1 Bio Rad Laboratories Basic Information
10.10.2 Bio Rad Laboratories Genomic Cancer Testing Product Overview
10.10.3 Bio Rad Laboratories Genomic Cancer Testing Product Market Performance
10.10.4 Bio Rad Laboratories Business Overview
10.10.5 Bio Rad Laboratories Recent Developments
10.11 Myriad Genetics
10.11.1 Myriad Genetics Basic Information
10.11.2 Myriad Genetics Genomic Cancer Testing Product Overview
10.11.3 Myriad Genetics Genomic Cancer Testing Product Market Performance
10.11.4 Myriad Genetics Business Overview
10.11.5 Myriad Genetics Recent Developments
11 GENOMIC CANCER TESTING MARKET FORECAST BY REGION
11.1 Global Genomic Cancer Testing Market Size Forecast
11.2 Global Genomic Cancer Testing Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Genomic Cancer Testing Market Size Forecast by Country
11.2.3 Asia Pacific Genomic Cancer Testing Market Size Forecast by Region
11.2.4 South America Genomic Cancer Testing Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Genomic Cancer Testing by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)
12.1 Global Genomic Cancer Testing Market Forecast by Type (2026-2033)
12.1.1 Global Forecasted Sales of Genomic Cancer Testing by Type (2026-2033)
12.1.2 Global Genomic Cancer Testing Market Size Forecast by Type (2026-2033)
12.1.3 Global Forecasted Price of Genomic Cancer Testing by Type (2026-2033)
12.2 Global Genomic Cancer Testing Market Forecast by Application (2026-2033)
12.2.1 Global Genomic Cancer Testing Sales (K Units) Forecast by Application
12.2.2 Global Genomic Cancer Testing Market Size (M USD) Forecast by Application (2026-2033)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Genomic Cancer Testing Market Size Comparison by Region (M USD)
Table 5. Global Genomic Cancer Testing Sales (K Units) by Manufacturers (2020-2025)
Table 6. Global Genomic Cancer Testing Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Genomic Cancer Testing Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global Genomic Cancer Testing Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Genomic Cancer Testing as of 2024)
Table 10. Global Market Genomic Cancer Testing Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 11. Manufacturers? Manufacturing Sites, Areas Served
Table 12. Manufacturers? Product Type
Table 13. Global Genomic Cancer Testing Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. Genomic Cancer Testing Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 25. Global Genomic Cancer Testing Sales by Type (K Units)
Table 26. Global Genomic Cancer Testing Market Size by Type (M USD)
Table 27. Global Genomic Cancer Testing Sales (K Units) by Type (2020-2025)
Table 28. Global Genomic Cancer Testing Sales Market Share by Type (2020-2025)
Table 29. Global Genomic Cancer Testing Market Size (M USD) by Type (2020-2025)
Table 30. Global Genomic Cancer Testing Market Size Share by Type (2020-2025)
Table 31. Global Genomic Cancer Testing Price (USD/Unit) by Type (2020-2025)
Table 32. Global Genomic Cancer Testing Sales (K Units) by Application
Table 33. Global Genomic Cancer Testing Market Size by Application
Table 34. Global Genomic Cancer Testing Sales by Application (2020-2025) & (K Units)
Table 35. Global Genomic Cancer Testing Sales Market Share by Application (2020-2025)
Table 36. Global Genomic Cancer Testing Market Size by Application (2020-2025) & (M USD)
Table 37. Global Genomic Cancer Testing Market Share by Application (2020-2025)
Table 38. Global Genomic Cancer Testing Sales Growth Rate by Application (2020-2025)
Table 39. Global Genomic Cancer Testing Sales by Region (2020-2025) & (K Units)
Table 40. Global Genomic Cancer Testing Sales Market Share by Region (2020-2025)
Table 41. Global Genomic Cancer Testing Market Size by Region (2020-2025) & (M USD)
Table 42. Global Genomic Cancer Testing Market Size Market Share by Region (2020-2025)
Table 43. North America Genomic Cancer Testing Sales by Country (2020-2025) & (K Units)
Table 44. North America Genomic Cancer Testing Market Size by Country (2020-2025) & (M USD)
Table 45. Europe Genomic Cancer Testing Sales by Country (2020-2025) & (K Units)
Table 46. Europe Genomic Cancer Testing Market Size by Country (2020-2025) & (M USD)
Table 47. Asia Pacific Genomic Cancer Testing Sales by Region (2020-2025) & (K Units)
Table 48. Asia Pacific Genomic Cancer Testing Market Size by Region (2020-2025) & (M USD)
Table 49. South America Genomic Cancer Testing Sales by Country (2020-2025) & (K Units)
Table 50. South America Genomic Cancer Testing Market Size by Country (2020-2025) & (M USD)
Table 51. Middle East and Africa Genomic Cancer Testing Sales by Region (2020-2025) & (K Units)
Table 52. Middle East and Africa Genomic Cancer Testing Market Size by Region (2020-2025) & (M USD)
Table 53. Global Genomic Cancer Testing Production (K Units) by Region(2020-2025)
Table 54. Global Genomic Cancer Testing Revenue (US$ Million) by Region (2020-2025)
Table 55. Global Genomic Cancer Testing Revenue Market Share by Region (2020-2025)
Table 56. Global Genomic Cancer Testing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 57. North America Genomic Cancer Testing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. Europe Genomic Cancer Testing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Japan Genomic Cancer Testing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. China Genomic Cancer Testing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. Devyser Basic Information
Table 62. Devyser Genomic Cancer Testing Product Overview
Table 63. Devyser Genomic Cancer Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 64. Devyser Business Overview
Table 65. Devyser SWOT Analysis
Table 66. Devyser Recent Developments
Table 67. Agendia Basic Information
Table 68. Agendia Genomic Cancer Testing Product Overview
Table 69. Agendia Genomic Cancer Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 70. Agendia Business Overview
Table 71. Agendia SWOT Analysis
Table 72. Agendia Recent Developments
Table 73. Illumina Basic Information
Table 74. Illumina Genomic Cancer Testing Product Overview
Table 75. Illumina Genomic Cancer Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 76. Illumina Business Overview
Table 77. Illumina SWOT Analysis
Table 78. Illumina Recent Developments
Table 79. Personal Genome Diagnostics Basic Information
Table 80. Personal Genome Diagnostics Genomic Cancer Testing Product Overview
Table 81. Personal Genome Diagnostics Genomic Cancer Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 82. Personal Genome Diagnostics Business Overview
Table 83. Personal Genome Diagnostics Recent Developments
Table 84. Veracyte Basic Information
Table 85. Veracyte Genomic Cancer Testing Product Overview
Table 86. Veracyte Genomic Cancer Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 87. Veracyte Business Overview
Table 88. Veracyte Recent Developments
Table 89. Pacific Biosciences of California Basic Information
Table 90. Pacific Biosciences of California Genomic Cancer Testing Product Overview
Table 91. Pacific Biosciences of California Genomic Cancer Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 92. Pacific Biosciences of California Business Overview
Table 93. Pacific Biosciences of California Recent Developments
Table 94. Qiagen Basic Information
Table 95. Qiagen Genomic Cancer Testing Product Overview
Table 96. Qiagen Genomic Cancer Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 97. Qiagen Business Overview
Table 98. Qiagen Recent Developments
Table 99. Agilent Technologies Basic Information
Table 100. Agilent Technologies Genomic Cancer Testing Product Overview
Table 101. Agilent Technologies Genomic Cancer Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 102. Agilent Technologies Business Overview
Table 103. Agilent Technologies Recent Developments
Table 104. Natera Basic Information
Table 105. Natera Genomic Cancer Testing Product Overview
Table 106. Natera Genomic Cancer Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 107. Natera Business Overview
Table 108. Natera Recent Developments
Table 109. Bio Rad Laboratories Basic Information
Table 110. Bio Rad Laboratories Genomic Cancer Testing Product Overview
Table 111. Bio Rad Laboratories Genomic Cancer Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 112. Bio Rad Laboratories Business Overview
Table 113. Bio Rad Laboratories Recent Developments
Table 114. Myriad Genetics Basic Information
Table 115. Myriad Genetics Genomic Cancer Testing Product Overview
Table 116. Myriad Genetics Genomic Cancer Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 117. Myriad Genetics Business Overview
Table 118. Myriad Genetics Recent Developments
Table 119. Global Genomic Cancer Testing Sales Forecast by Region (2026-2033) & (K Units)
Table 120. Global Genomic Cancer Testing Market Size Forecast by Region (2026-2033) & (M USD)
Table 121. North America Genomic Cancer Testing Sales Forecast by Country (2026-2033) & (K Units)
Table 122. North America Genomic Cancer Testing Market Size Forecast by Country (2026-2033) & (M USD)
Table 123. Europe Genomic Cancer Testing Sales Forecast by Country (2026-2033) & (K Units)
Table 124. Europe Genomic Cancer Testing Market Size Forecast by Country (2026-2033) & (M USD)
Table 125. Asia Pacific Genomic Cancer Testing Sales Forecast by Region (2026-2033) & (K Units)
Table 126. Asia Pacific Genomic Cancer Testing Market Size Forecast by Region (2026-2033) & (M USD)
Table 127. South America Genomic Cancer Testing Sales Forecast by Country (2026-2033) & (K Units)
Table 128. South America Genomic Cancer Testing Market Size Forecast by Country (2026-2033) & (M USD)
Table 129. Middle East and Africa Genomic Cancer Testing Sales Forecast by Country (2026-2033) & (Units)
Table 130. Middle East and Africa Genomic Cancer Testing Market Size Forecast by Country (2026-2033) & (M USD)
Table 131. Global Genomic Cancer Testing Sales Forecast by Type (2026-2033) & (K Units)
Table 132. Global Genomic Cancer Testing Market Size Forecast by Type (2026-2033) & (M USD)
Table 133. Global Genomic Cancer Testing Price Forecast by Type (2026-2033) & (USD/Unit)
Table 134. Global Genomic Cancer Testing Sales (K Units) Forecast by Application (2026-2033)
Table 135. Global Genomic Cancer Testing Market Size Forecast by Application (2026-2033) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Genomic Cancer Testing Market Size Comparison by Region (M USD)
Table 5. Global Genomic Cancer Testing Sales (K Units) by Manufacturers (2020-2025)
Table 6. Global Genomic Cancer Testing Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Genomic Cancer Testing Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global Genomic Cancer Testing Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Genomic Cancer Testing as of 2024)
Table 10. Global Market Genomic Cancer Testing Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 11. Manufacturers? Manufacturing Sites, Areas Served
Table 12. Manufacturers? Product Type
Table 13. Global Genomic Cancer Testing Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. Genomic Cancer Testing Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 25. Global Genomic Cancer Testing Sales by Type (K Units)
Table 26. Global Genomic Cancer Testing Market Size by Type (M USD)
Table 27. Global Genomic Cancer Testing Sales (K Units) by Type (2020-2025)
Table 28. Global Genomic Cancer Testing Sales Market Share by Type (2020-2025)
Table 29. Global Genomic Cancer Testing Market Size (M USD) by Type (2020-2025)
Table 30. Global Genomic Cancer Testing Market Size Share by Type (2020-2025)
Table 31. Global Genomic Cancer Testing Price (USD/Unit) by Type (2020-2025)
Table 32. Global Genomic Cancer Testing Sales (K Units) by Application
Table 33. Global Genomic Cancer Testing Market Size by Application
Table 34. Global Genomic Cancer Testing Sales by Application (2020-2025) & (K Units)
Table 35. Global Genomic Cancer Testing Sales Market Share by Application (2020-2025)
Table 36. Global Genomic Cancer Testing Market Size by Application (2020-2025) & (M USD)
Table 37. Global Genomic Cancer Testing Market Share by Application (2020-2025)
Table 38. Global Genomic Cancer Testing Sales Growth Rate by Application (2020-2025)
Table 39. Global Genomic Cancer Testing Sales by Region (2020-2025) & (K Units)
Table 40. Global Genomic Cancer Testing Sales Market Share by Region (2020-2025)
Table 41. Global Genomic Cancer Testing Market Size by Region (2020-2025) & (M USD)
Table 42. Global Genomic Cancer Testing Market Size Market Share by Region (2020-2025)
Table 43. North America Genomic Cancer Testing Sales by Country (2020-2025) & (K Units)
Table 44. North America Genomic Cancer Testing Market Size by Country (2020-2025) & (M USD)
Table 45. Europe Genomic Cancer Testing Sales by Country (2020-2025) & (K Units)
Table 46. Europe Genomic Cancer Testing Market Size by Country (2020-2025) & (M USD)
Table 47. Asia Pacific Genomic Cancer Testing Sales by Region (2020-2025) & (K Units)
Table 48. Asia Pacific Genomic Cancer Testing Market Size by Region (2020-2025) & (M USD)
Table 49. South America Genomic Cancer Testing Sales by Country (2020-2025) & (K Units)
Table 50. South America Genomic Cancer Testing Market Size by Country (2020-2025) & (M USD)
Table 51. Middle East and Africa Genomic Cancer Testing Sales by Region (2020-2025) & (K Units)
Table 52. Middle East and Africa Genomic Cancer Testing Market Size by Region (2020-2025) & (M USD)
Table 53. Global Genomic Cancer Testing Production (K Units) by Region(2020-2025)
Table 54. Global Genomic Cancer Testing Revenue (US$ Million) by Region (2020-2025)
Table 55. Global Genomic Cancer Testing Revenue Market Share by Region (2020-2025)
Table 56. Global Genomic Cancer Testing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 57. North America Genomic Cancer Testing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. Europe Genomic Cancer Testing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Japan Genomic Cancer Testing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. China Genomic Cancer Testing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. Devyser Basic Information
Table 62. Devyser Genomic Cancer Testing Product Overview
Table 63. Devyser Genomic Cancer Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 64. Devyser Business Overview
Table 65. Devyser SWOT Analysis
Table 66. Devyser Recent Developments
Table 67. Agendia Basic Information
Table 68. Agendia Genomic Cancer Testing Product Overview
Table 69. Agendia Genomic Cancer Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 70. Agendia Business Overview
Table 71. Agendia SWOT Analysis
Table 72. Agendia Recent Developments
Table 73. Illumina Basic Information
Table 74. Illumina Genomic Cancer Testing Product Overview
Table 75. Illumina Genomic Cancer Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 76. Illumina Business Overview
Table 77. Illumina SWOT Analysis
Table 78. Illumina Recent Developments
Table 79. Personal Genome Diagnostics Basic Information
Table 80. Personal Genome Diagnostics Genomic Cancer Testing Product Overview
Table 81. Personal Genome Diagnostics Genomic Cancer Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 82. Personal Genome Diagnostics Business Overview
Table 83. Personal Genome Diagnostics Recent Developments
Table 84. Veracyte Basic Information
Table 85. Veracyte Genomic Cancer Testing Product Overview
Table 86. Veracyte Genomic Cancer Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 87. Veracyte Business Overview
Table 88. Veracyte Recent Developments
Table 89. Pacific Biosciences of California Basic Information
Table 90. Pacific Biosciences of California Genomic Cancer Testing Product Overview
Table 91. Pacific Biosciences of California Genomic Cancer Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 92. Pacific Biosciences of California Business Overview
Table 93. Pacific Biosciences of California Recent Developments
Table 94. Qiagen Basic Information
Table 95. Qiagen Genomic Cancer Testing Product Overview
Table 96. Qiagen Genomic Cancer Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 97. Qiagen Business Overview
Table 98. Qiagen Recent Developments
Table 99. Agilent Technologies Basic Information
Table 100. Agilent Technologies Genomic Cancer Testing Product Overview
Table 101. Agilent Technologies Genomic Cancer Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 102. Agilent Technologies Business Overview
Table 103. Agilent Technologies Recent Developments
Table 104. Natera Basic Information
Table 105. Natera Genomic Cancer Testing Product Overview
Table 106. Natera Genomic Cancer Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 107. Natera Business Overview
Table 108. Natera Recent Developments
Table 109. Bio Rad Laboratories Basic Information
Table 110. Bio Rad Laboratories Genomic Cancer Testing Product Overview
Table 111. Bio Rad Laboratories Genomic Cancer Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 112. Bio Rad Laboratories Business Overview
Table 113. Bio Rad Laboratories Recent Developments
Table 114. Myriad Genetics Basic Information
Table 115. Myriad Genetics Genomic Cancer Testing Product Overview
Table 116. Myriad Genetics Genomic Cancer Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 117. Myriad Genetics Business Overview
Table 118. Myriad Genetics Recent Developments
Table 119. Global Genomic Cancer Testing Sales Forecast by Region (2026-2033) & (K Units)
Table 120. Global Genomic Cancer Testing Market Size Forecast by Region (2026-2033) & (M USD)
Table 121. North America Genomic Cancer Testing Sales Forecast by Country (2026-2033) & (K Units)
Table 122. North America Genomic Cancer Testing Market Size Forecast by Country (2026-2033) & (M USD)
Table 123. Europe Genomic Cancer Testing Sales Forecast by Country (2026-2033) & (K Units)
Table 124. Europe Genomic Cancer Testing Market Size Forecast by Country (2026-2033) & (M USD)
Table 125. Asia Pacific Genomic Cancer Testing Sales Forecast by Region (2026-2033) & (K Units)
Table 126. Asia Pacific Genomic Cancer Testing Market Size Forecast by Region (2026-2033) & (M USD)
Table 127. South America Genomic Cancer Testing Sales Forecast by Country (2026-2033) & (K Units)
Table 128. South America Genomic Cancer Testing Market Size Forecast by Country (2026-2033) & (M USD)
Table 129. Middle East and Africa Genomic Cancer Testing Sales Forecast by Country (2026-2033) & (Units)
Table 130. Middle East and Africa Genomic Cancer Testing Market Size Forecast by Country (2026-2033) & (M USD)
Table 131. Global Genomic Cancer Testing Sales Forecast by Type (2026-2033) & (K Units)
Table 132. Global Genomic Cancer Testing Market Size Forecast by Type (2026-2033) & (M USD)
Table 133. Global Genomic Cancer Testing Price Forecast by Type (2026-2033) & (USD/Unit)
Table 134. Global Genomic Cancer Testing Sales (K Units) Forecast by Application (2026-2033)
Table 135. Global Genomic Cancer Testing Market Size Forecast by Application (2026-2033) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Genomic Cancer Testing
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Genomic Cancer Testing Market Size (M USD), 2024-2033
Figure 5. Global Genomic Cancer Testing Market Size (M USD) (2020-2033)
Figure 6. Global Genomic Cancer Testing Sales (K Units) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Genomic Cancer Testing Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Genomic Cancer Testing Product Life Cycle
Figure 13. Genomic Cancer Testing Sales Share by Manufacturers in 2024
Figure 14. Global Genomic Cancer Testing Revenue Share by Manufacturers in 2024
Figure 15. Genomic Cancer Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Genomic Cancer Testing Average Price (USD/Unit) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Genomic Cancer Testing Revenue in 2024
Figure 18. Industry Chain Map of Genomic Cancer Testing
Figure 19. Global Genomic Cancer Testing Market PEST Analysis
Figure 20. Global Genomic Cancer Testing Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Genomic Cancer Testing Market Share by Type
Figure 27. Sales Market Share of Genomic Cancer Testing by Type (2020-2025)
Figure 28. Sales Market Share of Genomic Cancer Testing by Type in 2024
Figure 29. Market Size Share of Genomic Cancer Testing by Type (2020-2025)
Figure 30. Market Size Share of Genomic Cancer Testing by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Genomic Cancer Testing Market Share by Application
Figure 33. Global Genomic Cancer Testing Sales Market Share by Application (2020-2025)
Figure 34. Global Genomic Cancer Testing Sales Market Share by Application in 2024
Figure 35. Global Genomic Cancer Testing Market Share by Application (2020-2025)
Figure 36. Global Genomic Cancer Testing Market Share by Application in 2024
Figure 37. Global Genomic Cancer Testing Sales Growth Rate by Application (2020-2025)
Figure 38. Global Genomic Cancer Testing Sales Market Share by Region (2020-2025)
Figure 39. Global Genomic Cancer Testing Market Size Market Share by Region (2020-2025)
Figure 40. North America Genomic Cancer Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Genomic Cancer Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Genomic Cancer Testing Sales Market Share by Country in 2024
Figure 43. North America Genomic Cancer Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Genomic Cancer Testing Market Size Market Share by Country in 2024
Figure 45. U.S. Genomic Cancer Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Genomic Cancer Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Genomic Cancer Testing Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Genomic Cancer Testing Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Genomic Cancer Testing Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Genomic Cancer Testing Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Genomic Cancer Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Genomic Cancer Testing Sales Market Share by Country in 2024
Figure 53. Europe Genomic Cancer Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Genomic Cancer Testing Market Size Market Share by Country in 2024
Figure 55. Germany Genomic Cancer Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Genomic Cancer Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Genomic Cancer Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Genomic Cancer Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Genomic Cancer Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Genomic Cancer Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Genomic Cancer Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Genomic Cancer Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Genomic Cancer Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Genomic Cancer Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Genomic Cancer Testing Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Genomic Cancer Testing Sales Market Share by Region in 2024
Figure 67. Asia Pacific Genomic Cancer Testing Market Size Market Share by Region in 2024
Figure 68. China Genomic Cancer Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Genomic Cancer Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Genomic Cancer Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Genomic Cancer Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Genomic Cancer Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Genomic Cancer Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Genomic Cancer Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Genomic Cancer Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Genomic Cancer Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Genomic Cancer Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Genomic Cancer Testing Sales and Growth Rate (K Units)
Figure 79. South America Genomic Cancer Testing Sales Market Share by Country in 2024
Figure 80. South America Genomic Cancer Testing Market Size and Growth Rate (M USD)
Figure 81. South America Genomic Cancer Testing Market Size Market Share by Country in 2024
Figure 82. Brazil Genomic Cancer Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Genomic Cancer Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Genomic Cancer Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Genomic Cancer Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Genomic Cancer Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Genomic Cancer Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Genomic Cancer Testing Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Genomic Cancer Testing Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Genomic Cancer Testing Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Genomic Cancer Testing Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia Genomic Cancer Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Genomic Cancer Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Genomic Cancer Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Genomic Cancer Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Genomic Cancer Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Genomic Cancer Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Genomic Cancer Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Genomic Cancer Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Genomic Cancer Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Genomic Cancer Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Genomic Cancer Testing Production Market Share by Region (2020-2025)
Figure 103. North America Genomic Cancer Testing Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Genomic Cancer Testing Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Genomic Cancer Testing Production (K Units) Growth Rate (2020-2025)
Figure 106. China Genomic Cancer Testing Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Genomic Cancer Testing Sales Forecast by Volume (2020-2033) & (K Units)
Figure 108. Global Genomic Cancer Testing Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global Genomic Cancer Testing Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global Genomic Cancer Testing Market Share Forecast by Type (2026-2033)
Figure 111. Global Genomic Cancer Testing Sales Forecast by Application (2026-2033)
Figure 112. Global Genomic Cancer Testing Market Share Forecast by Application (2026-2033)
Figure 1. Product Picture of Genomic Cancer Testing
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Genomic Cancer Testing Market Size (M USD), 2024-2033
Figure 5. Global Genomic Cancer Testing Market Size (M USD) (2020-2033)
Figure 6. Global Genomic Cancer Testing Sales (K Units) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Genomic Cancer Testing Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Genomic Cancer Testing Product Life Cycle
Figure 13. Genomic Cancer Testing Sales Share by Manufacturers in 2024
Figure 14. Global Genomic Cancer Testing Revenue Share by Manufacturers in 2024
Figure 15. Genomic Cancer Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Genomic Cancer Testing Average Price (USD/Unit) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Genomic Cancer Testing Revenue in 2024
Figure 18. Industry Chain Map of Genomic Cancer Testing
Figure 19. Global Genomic Cancer Testing Market PEST Analysis
Figure 20. Global Genomic Cancer Testing Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Genomic Cancer Testing Market Share by Type
Figure 27. Sales Market Share of Genomic Cancer Testing by Type (2020-2025)
Figure 28. Sales Market Share of Genomic Cancer Testing by Type in 2024
Figure 29. Market Size Share of Genomic Cancer Testing by Type (2020-2025)
Figure 30. Market Size Share of Genomic Cancer Testing by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Genomic Cancer Testing Market Share by Application
Figure 33. Global Genomic Cancer Testing Sales Market Share by Application (2020-2025)
Figure 34. Global Genomic Cancer Testing Sales Market Share by Application in 2024
Figure 35. Global Genomic Cancer Testing Market Share by Application (2020-2025)
Figure 36. Global Genomic Cancer Testing Market Share by Application in 2024
Figure 37. Global Genomic Cancer Testing Sales Growth Rate by Application (2020-2025)
Figure 38. Global Genomic Cancer Testing Sales Market Share by Region (2020-2025)
Figure 39. Global Genomic Cancer Testing Market Size Market Share by Region (2020-2025)
Figure 40. North America Genomic Cancer Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Genomic Cancer Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Genomic Cancer Testing Sales Market Share by Country in 2024
Figure 43. North America Genomic Cancer Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Genomic Cancer Testing Market Size Market Share by Country in 2024
Figure 45. U.S. Genomic Cancer Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Genomic Cancer Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Genomic Cancer Testing Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Genomic Cancer Testing Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Genomic Cancer Testing Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Genomic Cancer Testing Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Genomic Cancer Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Genomic Cancer Testing Sales Market Share by Country in 2024
Figure 53. Europe Genomic Cancer Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Genomic Cancer Testing Market Size Market Share by Country in 2024
Figure 55. Germany Genomic Cancer Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Genomic Cancer Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Genomic Cancer Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Genomic Cancer Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Genomic Cancer Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Genomic Cancer Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Genomic Cancer Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Genomic Cancer Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Genomic Cancer Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Genomic Cancer Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Genomic Cancer Testing Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Genomic Cancer Testing Sales Market Share by Region in 2024
Figure 67. Asia Pacific Genomic Cancer Testing Market Size Market Share by Region in 2024
Figure 68. China Genomic Cancer Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Genomic Cancer Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Genomic Cancer Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Genomic Cancer Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Genomic Cancer Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Genomic Cancer Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Genomic Cancer Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Genomic Cancer Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Genomic Cancer Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Genomic Cancer Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Genomic Cancer Testing Sales and Growth Rate (K Units)
Figure 79. South America Genomic Cancer Testing Sales Market Share by Country in 2024
Figure 80. South America Genomic Cancer Testing Market Size and Growth Rate (M USD)
Figure 81. South America Genomic Cancer Testing Market Size Market Share by Country in 2024
Figure 82. Brazil Genomic Cancer Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Genomic Cancer Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Genomic Cancer Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Genomic Cancer Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Genomic Cancer Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Genomic Cancer Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Genomic Cancer Testing Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Genomic Cancer Testing Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Genomic Cancer Testing Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Genomic Cancer Testing Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia Genomic Cancer Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Genomic Cancer Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Genomic Cancer Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Genomic Cancer Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Genomic Cancer Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Genomic Cancer Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Genomic Cancer Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Genomic Cancer Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Genomic Cancer Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Genomic Cancer Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Genomic Cancer Testing Production Market Share by Region (2020-2025)
Figure 103. North America Genomic Cancer Testing Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Genomic Cancer Testing Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Genomic Cancer Testing Production (K Units) Growth Rate (2020-2025)
Figure 106. China Genomic Cancer Testing Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Genomic Cancer Testing Sales Forecast by Volume (2020-2033) & (K Units)
Figure 108. Global Genomic Cancer Testing Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global Genomic Cancer Testing Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global Genomic Cancer Testing Market Share Forecast by Type (2026-2033)
Figure 111. Global Genomic Cancer Testing Sales Forecast by Application (2026-2033)
Figure 112. Global Genomic Cancer Testing Market Share Forecast by Application (2026-2033)
